Per Källblad

Per Källblad

Chief Executive Officer at
Beactica Therapeutics AB
Health Technology
Commercial Services
Miscellaneous

Profile

Per Källblad is the founder of Beactica Therapeutics AB, serving as Chief Executive Officer since 2014, with the company founded in 2006.
Former jobs include Principal at Aventis, Inc., Senior Scientist at Medivir AB from 2004 to 2006, Principal at Rhone-Poulenc Rorer, Inc., Principal at Biovitrum AB, Principal at Tibotec Virco NV, Founding Scientist at De Novo Pharmaceuticals Ltd. from 1999 to 2004, Principal at Concept Life Sciences Integrated Discovery & Dev Services Ltd., Principal at Cancer Research UK, and Principal at Roche Corp.
Education includes a doctorate from the University of Cambridge.

Per Källblad active positions

CompaniesPositionStart
Chief Executive Officer 31/12/2005

Former positions of Per Källblad

CompaniesPositionEnd
MEDIVIR AB Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Per Källblad's experience

Training of Per Källblad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Miscellaneous

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Distribution Services

Roche Corp.